After overexpressing YTHDF2 in ocular melanoma cells (Fig. 6a), the anticancer effects of glycolysis inhibitors were partially compromised, including cell growth (Fig. 6b, c), colony formation (Fig. 6d, e) and migration (Fig. 6f, g). This evidence concerns the gene YTHDF2 and ocular melanoma.